| 10.65 Data as of 3:59pm ET |  +0.37 / +3.60%Today’s Change | 6.55 Today|||52-Week Range 14.46 | +18.60% Year-to-Date |
| Previous close | 10.28 |
| Today’s open | 10.27 |
| Day’s range | 10.13 - 10.89 |
| Volume | 245,988 |
| Average volume (3 months) | 105,919 |
| Market cap | $338.5M |
| Dividend yield | -- |
| Earnings growth (last year) | -175.56% |
| Earnings growth (this year) | +10.29% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -72.16% |
| P/E ratio | NM |
| Price/Sales | 25.00 |
| Price/Book | 9.42 |
| Today’s change | Today’s % change | |
|---|---|---|
| KMDAKamada Ltd | -0.07 | -0.64% |
| NVAXNovavax Inc | +0.01 | +0.52% |
| CRISCuris Inc | -0.01 | -0.29% |
| HPTXHyperion Therapeutic... | -0.12 | -0.58% |
| Next reporting date | August 8, 2013 |
| EPS forecast (this quarter) | -$0.09 |
| Annual revenue (last year) | $11.8M |
| Annual profit (last year) | -$11.1M |
| Net profit margin | -93.74% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chairman Peter A. Friedli |
President, Chief Executive Officer & Director Charles Randal Mills, PhD |
Corporate headquarters Columbia, Maryland |
.
